Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

Study suggests an approximately 2.5-year survival increase compared with placebo or no maintenance in patients with multiple myeloma.

The research and development process for prescription drugs could be streamlined with large-scale prospective biobank studies.

Caregivers need to carefully monitor comorbidities that accompany a COPD diagnosis.

Fenofibrate with 2-Deoxy-D-glucose shows success treating a variety of cancers.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Digestive hormone found to reduce liver fibrosis associated with cholestasis.

Protease inhibitors can frequently lead to cardiovascular disease, diabetes, and obesity.

Rinku A. Patel, PharmD, RPh, founder and CEO of KloudScript, discusses the optimal use of technology and data to improve patient care in specialty pharmacies.

Study finds a large proportion of breast cancer patients are receiving enough follow-up heart scans.

Findings will allow for improved screenings of drugs that treat MS.

Engineering bacteria to deliver HIV-1 neutralizing antibodies at the site where the virus enters the body may offer a cost-effective barrier to HIV-1 transmission.

Ryan White HIV/AIDS Program offers medical care and services for low income, uninsured, and underinsured individuals.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of the CSI Specialty Group, discusses improved communication among specialty drug manufacturers and health care providers.

Diet and physical activity found to decrease the risk of developing multiple cancer types.

Top news of the day from across the health care landscape.

Researchers evaluate the link between organ transplant and the increased likelihood of developing diabetes.

Edaravone previously granted Orphan Drug Designation by the FDA for amyotrophic lateral sclerosis.

Anti-TNF-a monoclonal antibody treats moderate-to-severe plaque psoriasis and moderate-to-severe rheumatoid arthritis.

ACOs found to generate modest savings on an annual per patient basis.

Family and friends of terminal patients may have overly optimistic expectations for survival.

Biosimilars show promise for treatment of treat autoimmune diseases and hematological cancers.

Docetaxel-induced peripheral neuropathy found in castrate-resistant metastatic prostate cancer.

Researchers explore the capability of natural killer cells.

Top news of the day from across the health care landscape.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses the use of technology to improve patient care in specialty pharmacy.

Study finds high out-of-pocket costs remain a barrier for initiation of oral cancer drugs.

Nivolumab (Opdivo) is a PD-1 immune checkpoint inhibitor that prevents an anti-tumor immune response.

Inotuzumab ozogamicin is a novel antibody-drug conjugate comprised of a monoclonal antibody that targets the surface cell antigen CD22.